Company ANGIOSOMA OTC Markets

Equities

SOAN

US03476L1026

Biotechnology & Medical Research

End-of-day quote OTC Markets 04:30:00 05/02/2024 am IST 5-day change 1st Jan Change
0.0009 USD -.--% Intraday chart for ANGIOSOMA +20.00% -.--%

Business Summary

GlobeStar Therapeutics Corporation (GlobeStar Therapeutics) is a clinical-stage pharmaceutical company. The Company is focused on introducing a patented formulation of drugs for the treatment of Multiple Sclerosis and other neurodegenerative diseases. The Company owns the global license from the inventors, who are based in Italy. The Company has acquired a license for a patented method of treating neurodegenerative diseases such as Multiple Sclerosis by administering a synergistically effective amount of the composition to an individual suffering from neurodegeneration and treating neurodegeneration. GlobeStar Therapeutics is initiating discussions with the Food and Drug Administration (FDA) on clinical trial design in preparation for FDA submission and approval pathway.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 128,991 0 0 92.42 %
Stock B 0 1,000,000 0 0
Stock C 0 509,988 0 0
Stock D 1 1,162,921,101 1,076,238,232 ( 92.55 %) 0

Shareholders

NameEquities%Valuation
2021 Pharma Associates LLC
5.010 %
58,260,334 5.010 % 58 260 $
17,042,253 1.465 % 17 042 $
11,000,000 0.9459 % 11 000 $
Ancora Family Wealth Advisors LLC
0.007567 %
88,000 0.007567 % 88 $
NameEquities%Valuation
1,000,000 100.00 % 1 000 $

Company contact information

GlobeStar Therapeutics Corp.

719 Jadwin Avenue

99352, Richland

+

http://www.globestartherapeutics.com
address ANGIOSOMA(SOAN)